As of September 26, 2026, Oura has an active public offering process underway: the smart ring and health-wearable maker filed a Form S-1 with the SEC on Thursday, September 3, 2026, for a planned Nasdaq listing under the ticker OURA, and on September 21, 2026 it filed Amendment No. 1 to that S-1 setting terms of $40 to $44 per share across 50 million shares, a total deal size of $2.0 billion to $2.2 billion. Only 13.5 million of those shares are new shares sold by the company; the other 36.5 million are being sold by existing stockholders, so most of the proceeds will not go to Oura. The original S-1 disclosed $1,214.5 million (about $1.21 billion) in revenue for the nine months ended June 30, 2026, up 74 percent year over year, with $60.8 million in net income, per Reuters. Coinbase opened US retail IPO allocation access starting with Oura on September 21, 2026, the same day the amended terms were filed. Renaissance Capital and MEXC report that pricing is expected the week of September 28, 2026, on Nasdaq, but that week has not arrived and no final price has been set.
segmara.com publishes educational private-market context and can route limited interest into account-based private follow-up. Public pages do not create an offer, allocation, payment instruction, investment advice, or issuer-affiliated workflow.
Reuters reported on September 3, 2026 that Oura, the smart ring and health-wearable maker, had filed a Form S-1 with the SEC, the standard registration statement for a US initial public offering. The filing set up a planned Nasdaq listing under the ticker OURA and disclosed $1,214.5 million (about $1.21 billion) in revenue for the nine months ended June 30, 2026, up 74 percent year over year, with $60.8 million in net income.
On September 21, 2026, Oura filed Amendment No. 1 to its S-1, setting a price range of $40 to $44 per share across 50 million shares, for a total deal size of $2.0 billion to $2.2 billion, according to Securities.io and Renaissance Capital. Fierce Healthcare reported on September 22, 2026 that Oura and its backers are aiming to raise up to $2.2 billion.
Of the 50 million shares in the offering, only 13.5 million are new shares sold by Oura itself; the remaining 36.5 million are being sold by existing stockholders. That split matters because only the company sold shares generate net proceeds for Oura; the rest is existing investors and insiders selling part of their holdings.
Coinbase opened US retail IPO allocation access starting with Oura on September 21, 2026, the same day the amended terms were filed, according to Securities.io. Renaissance Capital and MEXC report that pricing is expected the week of September 28, 2026, on Nasdaq.
None of that is a locked in date from Oura itself. The final price, exact date, and deal size are not set until the company and its underwriters price the offering. Oura's S-1 and its amendments are filed with the SEC and searchable on EDGAR, which covers only US filings; this is a US Nasdaq offering, not a foreign listing, so EDGAR is the right primary source to track it.
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
| Metric | Value | Context |
|---|---|---|
| Canonical route | /blog/when-will-oura-ipo | Stable URL path for AI and search extraction. |
| Article title | When Will Oura IPO? Nasdaq Pricing Expected Week of Sept. 28 | Main page topic. |
| Attached public sources | 3 | Number of citation links rendered at the bottom of the article. |
| Segmara listed companies | 51 | Live private-company listings in the public catalogue. |
| Priced listings | 37 | Catalogue listings with visible indicative or direct marks. |
| Request-quote listings | 14 | Catalogue listings where a public price is intentionally not invented. |
| Stage | Timing | Price / valuation signal | Interpretation |
|---|
| Chart metric | Score | Interpretation |
|---|---|---|
| Catalogue breadth | 100 / 100 | 51 public listings |
| Visible pricing coverage | 72 / 100 | 37 of 51 listings show a mark |
| Source depth | 58 / 100 | 3 source links |
The search behind 'When Will Oura IPO? Nasdaq Pricing Expected Week of Sept. 28' is an access-intent query. People want to know where they can start interest in Oura private-market exposure without needing a private equity relationship, fund connection, or insider network.
segmara.com turns that search into a simple path: browse the listing, create an account, choose the company, and start the private-share inquiry. Final pricing and availability still depend on the route, but the starting point is public and straightforward.
Segmara works as a private-market access layer for interested visitors. The site helps visitors discover private markets categories that were previously hard to research and moves them into an account-based inquiry in a few steps.
Illustrative map of where the old private-market process was hardest and where Segmara makes the starting point easier.
Segmara Pro
Segmara Pro sends a weekly Pipeline Brief and an alert the day a covered company's filing goes public or is first publicly reported, across 60+ private tech companies. $15 a month, cancel anytime.
Yes. Visitors can start with the free Oura tracker using email only, then decide whether a private follow-up makes sense. Availability, eligibility, pricing, allocation, transfer approval, documents, and final terms can still vary by route.
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: visitors can follow named private-company interest before any account, document upload, or payment step.
Open the free Oura tracker first. It is email-only and keeps the public step narrow while final availability, pricing, eligibility, and terms are handled only through private follow-up.
No exact pricing date has been announced by the company. Oura filed its S-1 on September 3, 2026, and amended it on September 21, 2026, with a $40 to $44 per share range; Renaissance Capital and MEXC report pricing is expected the week of September 28, 2026, on Nasdaq, but that is outside reporting, not a confirmed date from Oura.
According to Reuters' September 3, 2026 report on the filing, Oura disclosed $1,214.5 million (about $1.21 billion) in revenue for the nine months ended June 30, 2026, up 74 percent year over year, with $60.8 million in net income.
Amendment No. 1 to the S-1, filed September 21, 2026, set terms of $40 to $44 per share across 50 million shares, a total deal size of $2.0 billion to $2.2 billion. Fierce Healthcare reported on September 22, 2026 that Oura and its backers are aiming for up to $2.2 billion. Only 13.5 million of the 50 million shares are new company shares; the rest are being sold by existing stockholders.
Not through Segmara. Segmara is a research site and does not sell, broker, or arrange purchases of Oura shares, before or after listing. Oura's S-1 and its amendments are public filings on SEC EDGAR, which covers US filings, and Oura's planned listing is on Nasdaq under the ticker OURA.
Next step
If this article helped explain Oura, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account, and no allocation promise.
When a full account makes sense, Segmara can route limited interest into an account-based private follow-up. Availability, pricing, eligibility, allocation, transfer approval, liquidity, and final terms can vary by company and route.
Get the free tracker